Expand volunteer programme to bolster NHS workforce, charity says
The move could help with staffing problems in the health service as well as slashing the cost of relying on agencies that supply temporary staff, experts said.
The Volunteer to Career programme has been piloted by the charity Helpforce in 48 NHS organisations across England.
It provides training, mentorship and support to help volunteers transition to professional roles.
Helpforce is now urging the Government to consider the scheme as part of its upcoming 10 Year Health Plan, claiming it could help fill around 23,600 frontline vacancies and related study placements by the end of the current Parliament in 2029.
According to the charity, around 107,000 NHS secondary care roles in England are vacant and the annual cost of using agency and bank staff has topped £10 billion.
Amerjit Chohan, chief executive of Helpforce, said: 'The success of the Volunteer to Career programme to date has been significant.
'Together with our partners in NHS trusts and other organisations, we've helped people who are interested in healthcare careers but don't have a background in the field to gain valuable experience before applying for paid roles.
'Through expertly designed and structured pathways, volunteers can find their niche without the immediate pressure of employment, while being upskilled and given confidence to take into job interviews.
'Since we launched the pilot initiative in 2022, hundreds of people have taken part, with 55% of them successfully transitioning from volunteering roles to paid careers in healthcare or associated courses – such as in nursing and midwifery.
'Our analysis shows that with the right investment, there's clear potential to supersize the opportunity, with conservative capacity for each of the 215 NHS trusts in England to support an average of 50 volunteers annually.
'We urge the Government to consider Volunteer to Career expansion within its upcoming NHS 10-Year Health Plan, unleashing the potential of home-grown healthcare talent.'
It comes after Prime Minister Sir Keir Starmer set out a number of measures to help bring down immigration on Monday.
The White Paper includes plans to end care worker visas for overseas recruitment.
Think tanks the King's Fund and the Health Foundation have backed Helpforce's call to the Government.
Dr Jennifer Dixon, Health Foundation chief executive, said the results of the pilot have been 'significant' and scaling it up ' has to be worthy of serious consideration by a government that's eager to get people back to work'.
Sarah Woolnough, chief executive of the King's Fund, added: 'At a time when the NHS is severely stretched and tackling long-standing and chronic workforce shortages, Helpforce is doing excellent, innovative work to support volunteers to explore opportunities for an NHS career.
'To implement Volunteer to Career on a mass scale would require strategic investment in volunteer managers across NHS Trusts, but such investment would likely be cost-effective when set against paying high fees to agencies that supply temporary staff and helping to reduce the health services' reliance on recruiting large numbers of healthcare staff from overseas.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
26 minutes ago
- The Independent
Psychological support system opens to infected blood victims
Thousands of people impacted by the infected blood scandal in England will be able to self refer to a bespoke psychological support NHS service, officials have announced. The nationwide service began a phased rollout in September, and is now open to people infected and affected across the country. The Infected Blood Psychological Service will include talking therapies; peer support and psychosocial support, NHS England said. More than 30,000 people in the UK were infected with HIV and hepatitis C after they were given contaminated blood and blood products between the 1970s and early 1990s. And more than 3,000 people have died as a result, while survivors are living with lifelong health implications. The new service is open to victims of the scandal as well as bereaved partners, parents, children and their extended families. People can self refer by phone or can be referred to the service by their GP. Officials said that a specialist therapist will help create tailored mental health plans for those in need of support. Claire Murdoch, national mental health director at NHS England, said: 'The contaminated blood scandal and the subsequent long fight for answers have had life-altering physical and psychological impacts for thousands across the country and the NHS is determined to ensure that anyone infected or affected can receive evidence-based support and treatment. 'It has been so important that the Infected Blood Psychological Service has been co-designed with members of the infected blood community to ensure the best and most personalised care possible, and we are very grateful to all our partners who have helped establish these vital new services.' Nicola Leahey, from Lancashire, was infected with Hepatitis C following blood transfusions in 1975 and/or 1980, and was part of the expert advisory group to the new service. 'After my diagnosis, I felt that my body had been violated, that I had been physically and mentally abused, stripped of my dignity, my self-esteem diminished, I mourned lost opportunities, I felt betrayed,' she said. 'So many of us have long awaited the opportunity to have professional support to try to cope with the trauma and life-long effects that we've been subjected to. 'I'm thrilled that this much-needed service is now operational for both those infected and affected members of the infected blood community across England.' Professor Meghana Pandit, co-national medical director for secondary care at NHS England, added: 'Following the recommendations of the Inquiry, this new service represents a vital step in ensuring patients and families affected in England can be offered tailored psychological treatment and support, and we are pleased that specialist clinics are now open in all areas of England. 'This bespoke psychological treatment is already making a difference to the lives of the first people to access it, and we now want to ensure everyone eligible is aware of the services provided.'
The Herald Scotland
28 minutes ago
- The Herald Scotland
Women with genetic cancer risk being ‘missed' due to testing gaps
Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'
South Wales Argus
33 minutes ago
- South Wales Argus
Women with genetic cancer risk being ‘missed' due to testing gaps
A lack of testing for Lynch syndrome also means some cancer patients are unaware of their risk of developing other cancers, academics said. Lynch syndrome is a rare condition which runs in families which puts people at a higher risk of developing cancers of the bowel, womb and ovaries. It is caused by a mutation in the gene that fixes mistakes in DNA when it is copied, which can lead to uncontrolled cell growth. Patients with bowel or womb cancer should have their tumours assessed for markers of Lynch syndrome, according to guidance for the NHS. If these markers are identified, patients should be referred for genetic testing so the diagnosis can be confirmed and they can get support and advice about cancer risk for themselves and their family. A new study by academics at the University of Edinburgh found not all womb cancer patients are being sent for genetic testing. Researchers examined data on 2,500 womb cancer patients across the UK and Ireland between 2022 and 2023. We have launched a Guide to #LynchSyndrome to help provide information and support to anyone who thinks they may have it, that it may run in the family, or have found out they have — The Eve Appeal (@eveappeal) February 13, 2023 They found that 91% of tumours were tested for markers of Lynch syndrome, but the test results were not routinely communicated to the wider clinical team. This means that follow-up genetic counselling and blood tests were not always arranged. Of the 181 participants eligible for genetic counselling, just under two-thirds (64%) were referred for appointments, according to the study, which has been published in the journal BMJ Oncology. Researchers said those who were referred faced long waits, resulting in high dropout rates, meaning only 48% of those eligible went on to get the test. Today's #LynchSyndromeAwarenessDay. Our policy team sat down with our supporter, Jane, to share her experience. As well as highlighting what else needs to be done to improve Lynch syndrome care. Read our blog: — Bowel Cancer UK (@bowelcanceruk) March 22, 2025 Experts from the university said gaps in testing mean some womb cancer patients with Lynch syndrome go undetected. Family members are also left vulnerable to cancer risk, unaware they may have the condition. Dr Neil Ryan, from the University of Edinburgh, who leads the UK audit and research collaborative in obstetrics and gynaecology, said: 'Despite clear guidance and excellent rates of tumour testing, too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 'This not only denies them the chance to reduce their future cancer risk but also prevents their relatives from being tested and protected. 'Tumour testing is only cost-effective if it leads to diagnosis — we urgently need to make mainstream testing truly mainstream.'
